Mark X. Sliwkowski
Molecular Oncology (United States)(US)
Publications by Year
Research Areas
HER2/EGFR in Cancer Research, Monoclonal and Polyclonal Antibodies Research, Lung Cancer Treatments and Mutations, Radiopharmaceutical Chemistry and Applications, Peptidase Inhibition and Analysis
Most-Cited Works
- → Untangling the ErbB signalling network(2001)6,890 cited
- → Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody–Cytotoxic Drug Conjugate(2008)1,659 cited
- → Structure of the Epidermal Growth Factor Receptor Kinase Domain Alone and in Complex with a 4-Anilinoquinazoline Inhibitor(2002)1,487 cited
- → Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index(2008)1,323 cited
- → Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex(2004)1,103 cited
- → Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates(2012)980 cited
- → Identification of Heregulin, a Specific Activator of p185 erbB2